Costain Group PLC (LON:COST)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	436	285	175	108	147	163
Market Cap Growth	62.39%	62.39%	61.97%	-26.23%	-9.80%	-5.70%
Enterprise Value	303	142	67	42	71	54
Last Close Price	1.62	1.04	0.61	0.38	0.51	0.57
PE Ratio	14.63	9.31	7.94	4.18	-	-
Forward PE	11.65	7.95	5.61	4.10	6.07	7.87
PS Ratio	0.35	0.23	0.13	0.08	0.13	0.17
PB Ratio	1.85	1.21	0.80	0.51	0.74	1.04
P/TBV Ratio	2.36	1.54	1.01	0.68	1.00	1.56
P/FCF Ratio	11.72	7.66	2.51	7.79	5.10	-
P/OCF Ratio	10.21	6.67	2.51	7.68	4.98	-
EV/Sales Ratio	0.24	0.11	0.05	0.03	0.06	0.06
EV/EBITDA Ratio	5.24	3.05	1.48	1.01	-	-
EV/EBIT Ratio	6.64	3.10	1.56	1.11	-	-
EV/FCF Ratio	8.15	3.81	0.97	3.00	2.47	-
Debt / Equity Ratio	0.11	0.11	0.11	0.14	0.33	0.51
Debt / EBITDA Ratio	0.45	0.45	0.41	0.61	14.71	-
Debt / FCF Ratio	0.69	0.69	0.35	2.12	2.30	-
Asset Turnover	2.30	2.30	2.59	2.79	2.22	1.88
Inventory Turnover	-	-	-	5314.80	2433.33	1081.05
Quick Ratio	1.11	1.11	1.14	1.14	1.15	1.29
Current Ratio	1.32	1.32	1.30	1.27	1.28	1.39
Return on Equity (ROE)	13.45%	13.45%	10.27%	12.63%	-3.26%	-49.65%
Return on Assets (ROA)	5.24%	5.24%	5.26%	4.61%	-1.16%	-9.86%
Return on Capital (ROIC)	11.31%	11.31%	11.17%	9.29%	-2.37%	-19.02%
Return on Capital Employed (ROCE)	18.30%	18.30%	18.40%	16.00%	-	-
Earnings Yield	7.02%	10.74%	12.60%	23.91%	-3.95%	-47.92%
FCF Yield	8.53%	13.06%	39.79%	12.83%	19.61%	-29.18%
Dividend Yield	1.48%	2.31%	1.96%	-	-	-
Payout Ratio	10.46%	10.46%	4.98%	-	-	-
Buyback Yield / Dilution	2.66%	2.66%	-1.95%	1.18%	-31.58%	-97.40%
Total Shareholder Return	4.13%	4.97%	0.01%	1.18%	-31.58%	-97.40%

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.